| Mrs Linda J Badillo, MD | |
|
Renal Hypertension Center, 14134 Nephrone Lane, Hudson, FL 34667 | |
| (727) 863-5418 | |
| (727) 869-8626 |
| Full Name | Mrs Linda J Badillo |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 35 Years |
| Location | Renal Hypertension Center, Hudson, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871588350 | NPI | - | NPPES |
| 2504896 | Other | GHI | |
| 593068073 | Other | HUMANA | |
| 0004646644 | Other | AETNA | |
| 1488952 | Other | CIGNA | |
| 593068073 | Other | PCHS | |
| PRO0018 | Other | QUALITY/DELTA | |
| 593068073 | Other | HUMANA MILITARY | |
| 818295 | Other | FIRST HEALTH | |
| 09597 | Other | WELLCARE | |
| 000002512762 | Other | PRINCIPAL | |
| 01243 | Other | UNIVERSAL | |
| 10501401 | Other | CITRUS HEALTH CARE | |
| 818295 | Other | CCN | |
| 1007ID# | Other | OPTIMUM | |
| 214617 | Other | AVMED | |
| 376839200 | Medicaid | FL | |
| 593068073 | Other | SOUTHCARE | |
| 593068073 | Other | BEECH STREET |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | ME66669 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Port Richey Kidney Center | Port richey, FL | Dialysis facility |
| Hernando Home Training | Spring hill, FL | Dialysis facility |
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mk Acharya Md Pa And Pm Reddy Md | 7012981350 | 53 |
News Archive
The University of Montreal Hospital Research Centre has been awarded a grant of US$2 million from the National Institutes of Health to pilot the Canadian component of a study to determine the optimal amount of blood to transfuse in anemic patients who have suffered a myocardial infarction.
Nymox Pharmaceutical Corporation reported today positive new results from pooled analysis of completed clinical trials of NX-1207, the Company's investigational drug for BPH. The trial data shows that patients receiving NX-1207 recorded significant quantitative improvement in the important symptom of urgent need to urinate.
rEVO Biologics announced today the results of a major retrospective study analysis of its pivotal phase 3 studies which demonstrate that pregnant patients with hereditary antithrombin deficiency (HD) benefit from ATryn Antithrombin (Recombinant) therapy to prevent venous thromboembolic events (VTE).
A new survey study links belief in the concept of social Darwinism with certain dysfunctional psychological characteristics, such as exploitative attitudes towards others, hostility, and low self-esteem.
A new study published on the preprint server bioRxiv in May 2020 reports the setting up of a system to help track new mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is behind the current COVID-19 pandemic. This will help analyze mutations to find and track the spread of those that are most likely to increase the pathogenicity of the virus, either by making it easier to transmit or by enhancing its resistance to treatment.
› Verified 9 days ago
| Entity Name | Mk Acharya Md Pa & Pm Reddy Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780684795 PECOS PAC ID: 7012981350 Enrollment ID: O20040823001373 |
News Archive
The University of Montreal Hospital Research Centre has been awarded a grant of US$2 million from the National Institutes of Health to pilot the Canadian component of a study to determine the optimal amount of blood to transfuse in anemic patients who have suffered a myocardial infarction.
Nymox Pharmaceutical Corporation reported today positive new results from pooled analysis of completed clinical trials of NX-1207, the Company's investigational drug for BPH. The trial data shows that patients receiving NX-1207 recorded significant quantitative improvement in the important symptom of urgent need to urinate.
rEVO Biologics announced today the results of a major retrospective study analysis of its pivotal phase 3 studies which demonstrate that pregnant patients with hereditary antithrombin deficiency (HD) benefit from ATryn Antithrombin (Recombinant) therapy to prevent venous thromboembolic events (VTE).
A new survey study links belief in the concept of social Darwinism with certain dysfunctional psychological characteristics, such as exploitative attitudes towards others, hostility, and low self-esteem.
A new study published on the preprint server bioRxiv in May 2020 reports the setting up of a system to help track new mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is behind the current COVID-19 pandemic. This will help analyze mutations to find and track the spread of those that are most likely to increase the pathogenicity of the virus, either by making it easier to transmit or by enhancing its resistance to treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Linda J Badillo, MD Renal Hypertension Center, 14134 Nephrone Lane, Hudson, FL 34667 Ph: (727) 863-5418 | Mrs Linda J Badillo, MD Renal Hypertension Center, 14134 Nephrone Lane, Hudson, FL 34667 Ph: (727) 863-5418 |
News Archive
The University of Montreal Hospital Research Centre has been awarded a grant of US$2 million from the National Institutes of Health to pilot the Canadian component of a study to determine the optimal amount of blood to transfuse in anemic patients who have suffered a myocardial infarction.
Nymox Pharmaceutical Corporation reported today positive new results from pooled analysis of completed clinical trials of NX-1207, the Company's investigational drug for BPH. The trial data shows that patients receiving NX-1207 recorded significant quantitative improvement in the important symptom of urgent need to urinate.
rEVO Biologics announced today the results of a major retrospective study analysis of its pivotal phase 3 studies which demonstrate that pregnant patients with hereditary antithrombin deficiency (HD) benefit from ATryn Antithrombin (Recombinant) therapy to prevent venous thromboembolic events (VTE).
A new survey study links belief in the concept of social Darwinism with certain dysfunctional psychological characteristics, such as exploitative attitudes towards others, hostility, and low self-esteem.
A new study published on the preprint server bioRxiv in May 2020 reports the setting up of a system to help track new mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is behind the current COVID-19 pandemic. This will help analyze mutations to find and track the spread of those that are most likely to increase the pathogenicity of the virus, either by making it easier to transmit or by enhancing its resistance to treatment.
› Verified 9 days ago
Dr. Deborah Saepharn, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2966 | |
Ramya Pinnamaneni, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 14100 Fivay Rd Ste 380, Hudson, FL 34667 Phone: 727-868-9208 Fax: 727-868-6420 | |
Dr. Domenick J Sorresso, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7614 Jacque Rd Ste C, Hudson, FL 34667 Phone: 727-857-5967 Fax: 727-857-5972 | |
Dr. Anthony Maurice Salibi, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2966 Fax: 727-819-2928 | |
Dr. Nicholas Cohen Kolinsky, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2966 Fax: 727-819-2928 | |
Dr. Hanan Gruhonjic, MD Nephrology Medicare: Medicare Enrolled Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2966 | |
Benjamin Kuritzky, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7651 Medical Dr, Hudson, FL 34667 Phone: 727-868-9208 Fax: 727-868-6420 |